BMC Research Notes · 2019 · 16 citations · 21 references
Public HealthImmunologyInfectious DiseasesImmunology Of Infectious DiseasesInfectious Disease EpidemiologyTuberculosis ControlAntiretroviral TherapyHiv EpidemiologyHiv TestingLatent Tuberculosis InfectionTuberculosis Diagnostic TestingTuberculosis EpidemiologyBlood Sample CollectionCd4 Cell Count MonitoringHiv ArtHuman Immunodeficiency Virus-associated TuberculosisInfection Risk FactorsTransmission Risk FactorsTuberculosis Reactivation
OBJECTIVE: Immuno-compromised individuals with latent tuberculosis infection (LTBI) are at an increased risk for tuberculosis reactivation compared with the general population. The aim of this study was to determine the prevalence of latent tuberculosis infection among people living with human immunodeficiency virus (PLWH) and apparently healthy blood donors. Human Immunodeficiency Virus positive individuals and for the purpose of comparison apparently healthy blood donors were enrolled. Blood sample was collected and tested for LTBI using QuantiFeron-TB Gold In-Tube assay (QFT-GIT) and CD4+ T cell count was determined by using BD FACS count. RESULTS: The overall prevalence of LTBI regardless of HIV status was 46%. The prevalence of LTBI among PLWH was 44% and that of blood donors 48%. ART naïve HIV positive patients were three times more likely to have LTBI than patients under ART treatment (P = 0.04). Data also showed statistically significant negative association between previous or current preventive INH therapy and LTBI among HIV positive cases (P = 0.005). The proportion of LTBI was slightly lower among HIV positive individuals than apparently healthy blood donors. Nevertheless, HIV positive individuals should be screened for LTBI and take INH prophylaxis.
21
Global tuberculosis report (2014)
L.A. Gabbasova, E.R. Experts Who · 2014 · 13.2K citations
Ajit Lalvani, Punam Nagvenkar, Zarir Udwadia et al. · The Journal of Infectious Diseases · 2001 · 344 citations